rs17118552
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001113498.3(MDGA2):c.281-103804T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0544 in 152,230 control chromosomes in the GnomAD database, including 248 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.054 ( 248 hom., cov: 32)
Consequence
MDGA2
NM_001113498.3 intron
NM_001113498.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.273
Publications
4 publications found
Genes affected
MDGA2 (HGNC:19835): (MAM domain containing glycosylphosphatidylinositol anchor 2) Predicted to be involved in regulation of presynapse assembly; regulation of synaptic membrane adhesion; and spinal cord motor neuron differentiation. Predicted to act upstream of or within neuron migration and pattern specification process. Predicted to be located in extracellular region and plasma membrane. Predicted to be active in GABA-ergic synapse and glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0856 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MDGA2 | NM_001113498.3 | c.281-103804T>C | intron_variant | Intron 1 of 16 | ENST00000399232.8 | NP_001106970.4 | ||
| MDGA2 | XM_011536522.4 | c.281-103804T>C | intron_variant | Intron 1 of 9 | XP_011534824.1 | |||
| MDGA2 | XM_047431051.1 | c.281-103804T>C | intron_variant | Intron 1 of 7 | XP_047287007.1 | |||
| MDGA2 | XM_017021061.3 | c.281-103804T>C | intron_variant | Intron 1 of 7 | XP_016876550.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0544 AC: 8279AN: 152112Hom.: 249 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8279
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0544 AC: 8280AN: 152230Hom.: 248 Cov.: 32 AF XY: 0.0551 AC XY: 4098AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
8280
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
4098
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
3654
AN:
41546
American (AMR)
AF:
AC:
531
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
67
AN:
3472
East Asian (EAS)
AF:
AC:
5
AN:
5178
South Asian (SAS)
AF:
AC:
268
AN:
4828
European-Finnish (FIN)
AF:
AC:
545
AN:
10604
Middle Eastern (MID)
AF:
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3075
AN:
67988
Other (OTH)
AF:
AC:
108
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
400
799
1199
1598
1998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
98
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.